 Telegraph.co.uk |
Bristol-Myers Strikes $438 Million Deal With Reckitt For Latin America …
Fox Business Bristol-Myers Squibb Co. (BMY) has struck a deal under which Reckitt Benckiser Group PLC (RBGLY) will pay it an upfront amount of $438 million for the exclusive rights to sell certain over-the-counter medicines across Latin America for three years. "As … Reckitt Benckiser and GlaxoSmithKline target Latin America Reckitt Benckiser Signs $482 Million OTC Pact With Bristol-Myers Bristol-Myers signs $482 million deal with Reckitt Benckiser |
